Haleon plc
NYSE:HLNDrug Manufacturers - Specialty & Generic
+$0.08 today
- Market cap
- $39.85B
- Beta
- 0.25
- P/E (TTM)
- 29.2
- EPS (TTM)
- $0.11
- Dividend yield
- 2.13%
Volume 19.46M
Average 8.79M
HLN Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Haleon plcNYSE: HLN
Financing Cash Flow · Q4 FY2025 · quarter ended Dec 2025
Financing cash flow turns negative
Q4 FY2025 financing cash flow was -£528.76M, compared with £0 a year earlier.
Context
- Financing cash flow amounted to 23.2% of revenue in FY2025, up 9.5 pp from a year earlier.
- Financing cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
GBP · from the cash flow
- Latest · FY2025
- (2.55B) GBP
- Year-over-year change
- -66.2%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.55B) | -66.2% |
| FY2024 | 2024-12-31 | (1.54B) | +2.0% |
| FY2023 | 2023-12-31 | (1.57B) | -122.7% |
| FY2022 | 2022-12-31 | 6.91B | +659.1% |
| FY2021 | 2021-12-31 | (1.24B) | — |
Financing Cash Flow vs competitors
How HLN compares with its peers on the latest reported figures
- Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +66.2% is the highest of 6, against a peer median of -6.1%.
- Financing cash flow amounts to 23.2% of revenue for HLN, versus a peer median of 14.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.63B USD | +14.5% | +50.7% | 17.1% | |
| FY2025 | £2.55B GBP | +66.2% | — | 23.2% | |
| LTM Jun 2026 | £2.53B GBP | -29.6% | — | 7.6% | |
| LTM Sep 2026 | $2.43B USD | +56.3% | +5.1% | 15.6% | |
| LTM Sep 2026 | $766.4M USD | -6.4% | +112.6% | 12.3% | |
| LTM Jun 2026 | $578.8M USD | -6.1% | — | 14.0% | |
| Peer median (excluding HLN) | — | -6.1% | +50.7% | 14.0% | |
Competitors are the stored peer set for HLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.39B | 1.12B | 1.3B | 1.44B | 1.63B |
| Depreciation & Amortization | 268M | 287M | 309M | 324M | 352.11M |
| Deferred Income Tax | 197M | 62M | 0 | 0 | 0 |
| Stock-Based Compensation | 59M | 78M | 88M | 102M | 0 |
| Change in Working Capital | (152M) | 181M | (107M) | 48M | 250.39M |
| Accounts Receivables | 14M | (85M) | 38M | (312M) | (63.58M) |
| Inventory | (17M) | (292M) | (131M) | 216M | 130.09M |
| Accounts Payables | 41M | 387M | 112M | 0 | 122.26M |
| Other Working Capital | (190M) | 171M | (126M) | 144M | 61.62M |
| Other Non-Cash Items | (406M) | 336M | 506.04M | 385M | 52.82M |
| Operating Cash Flow | 1.36B | 2.06B | 2.1B | 2.3B | 2.29B |
| Capital Expenditures | (298M) | (328M) | (336M) | (250M) | (314.94M) |
| Acquisitions (Net) | 112M | 9.21B | (71M) | 0 | (157.47M) |
| Purchases of Investments | (112M) | (9.21B) | 0 | 0 | (5.87M) |
| Sales of Investments | 100M | 700M | 0 | 0 | 0 |
| Other Investing Activities | 165M | (9.16B) | 171M | 778M | 0 |
| Investing Cash Flow | (33M) | (8.78B) | (134M) | 528M | (567.29M) |
| Debt Repayment | 8M | 9.49B | (553M) | 592M | (1.28B) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | (38M) | (121M) | (639.67M) |
| Dividends Paid | (1.15B) | (2.68B) | (388M) | (570M) | (598.59M) |
| Other Financing Activities | (96M) | 107M | (589M) | (1.44B) | (39.12M) |
| Financing Cash Flow | (1.24B) | 6.91B | (1.57B) | (1.54B) | (2.55B) |
| Effect of Forex Changes | (5M) | 15M | (15M) | (79M) | 66.6M |
| Net Change in Cash | 82M | 205M | 383M | 1.21B | (769.66M) |
| Free Cash Flow | 1.06B | 1.74B | 1.76B | 2.05B | 1.97B |
Haleon plc
NYSE:HLN
Intrinsic Alpha fair value
Locked
Current Price
$9.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.